Use of intravenous short-acting beta-2 agonist in addition to standard first-line treatment versus placebo in children and adolescents with acute severe asthma exacerbation: a systematic review and meta-analysis
{{output}}
Importance: The role of intravenous short-acting beta-2 agonist (SABA) in acute asthma in childhood is unclear. Objectives: To assess the safet... ...
